A cell-permeable dipeptide that potently antagonizes PPARγ (Kd = 8.34 µM); reversibly and competitively blocks activation of PPARγ by rosiglitazone (IC50 = 8-32 µM); active in vivo, abolishing the protective effects of rosiglitazone in experimental spinal cord injury in rats.